Tenofovir-induced renal tubular dysfunction presenting with hypocalcaemia.
Williams
John
J
Department of Infection and Travel Medicine, The James Cook University Hospital, Marton Rd, Middlesbrough TS4 3BW, UK. johnwilliams@doctors.net.uk
Chadwick
David R
DR
D000225:Adenine / Q000009:adverse effects / Q000031:analogs & derivatives*; D019380:Anti-HIV Agents / Q000009:adverse effects*; D050071:Bone Density Conservation Agents / Q000627:therapeutic use; D005198:Fanconi Syndrome / Q000139:chemically induced* / Q000175:diagnosis / Q000188:drug therapy; D015658:HIV Infections / Q000188:drug therapy*; D006801:Humans; D006887:Hydroxycholecalciferols / Q000627:therapeutic use; D006996:Hypocalcemia / Q000139:chemically induced* / Q000209:etiology; D008297:Male; D008875:Middle Aged; D063065:Organophosphonates / Q000009:adverse effects*; D010710:Phosphates / Q000627:therapeutic use; D000068698:Tenofovir; D016896:Treatment Outcome
D019380:Anti-HIV Agents; D050071:Bone Density Conservation Agents; D006887:Hydroxycholecalciferols; D063065:Organophosphonates; D010710:Phosphates; D000068698:Tenofovir; D000225:Adenine; C008088:alfacalcidol